α-lipoic acid reduces hypertension and increases baroreflex sensitivity in renovascular hypertensive rats

Molecules

Volumn 17, Issue 11, 2012, Pages 13357-13367

  Queiroz, Thyago M ^a   Guimarães, Drielle D ^a   Mendes Junior, Leônidas G ^a   Braga, Valdir A ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

2K1C; Blood pressure; Lipoic acid; Parasympathetic; Reactive oxygen species; Sympathetic

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; THIOCTIC ACID;

ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; HEART RATE; MALE; PRESSORECEPTOR REFLEX; RAT; RENOVASCULAR HYPERTENSION; WISTAR RAT;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BAROREFLEX; BLOOD PRESSURE; HEART RATE; HYPERTENSION, RENOVASCULAR; MALE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHENYLEPHRINE; RATS; RATS, WISTAR; THIOCTIC ACID;

EID: 84870203851     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171113357     Document Type: Article

References (50)

1. Reed, L. Multienzyme complexes. Acc. Chem. Res. 1974, 7, 40-46.
2. Shay, K.P.; Moreau, R.F.; Smith, E.J.; Smith, A.R.; Hagen, T.M. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta 2009, 1790, 1149-1160.
3. Takaoka, M.; Kobayashi, Y.; Yuba, M.; Ohkita, M.; Matsumura, Y. Effects of α-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur. J. Pharm. 2001, 424, 121-129.
4. Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J. Nutr. Biochem. 2003, 14, 288-294.
5. Biewenga, G.P.; Haenen, G.R.M.; Bast, A. The pharmacology of the antioxidant lipoic acid. Gen. Pharm. 1997, 29, 315-331.
6. Heinisch, B.B.; Francesconi, M.; Mittermayer, F.; Schaller, G.; Gouya, G.; Wolzt, M.; Pleiner, J. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: A placebo-controlled randomized trial. Eur. J. Clin. Investig. 2010, 40, 148-154.
7. Braga, V.A.; Antunes, V.R.; Machado, B.H. Autonomic and respiratory responses to microinjection of L-glutamate into the commissural subnucleus of the NTS in the working heart-brainstem preparation of the rat. Brain Res. 2006, 1093, 150-160.
8. Simic, D.V.; Mimic-Oka, J.; Pljesa-Ercegovac, M.; Savic-Radojevic, A.; Opacic, M.; Matic, D.; Ianovic, B.; Simic, T. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J. Hum. Hypertens. 2006, 20, 149-155.
9. Matteucci, E.; Giampietro, O. Thiol Signalling Network with an Eye to Diabetes. Molecules 2010, 15, 8890-8903.
10. Kitiyakara, C.; Wilcox, C.S. Antioxidants for hypertension. Curr. Opin. Nephrol. Hypertens. 1998, 7, 531-538.
11. Houston, M.C. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog. Cardiovasc. Dis. 2005, 47, 396-449.
12. Braga, V.A.; Burmeister, M.A.; Zhou, Y.; Sharma, R.V.; Davisson, R.L. Selective ablation of AT1a receptors in rostral ventrolateral medulla (RVLM) prevents chronic angiotensin-II-dependent hypertension in part by reducing oxidant stress in this region. Hypertension 2008, 52, e36.
13. Botelho-Ono, M.S.; Pina, H.V.; Sousa, K.H.F.; Nunes, F.C.; Medeiros, I.A.; Braga, V.A. Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats. Auton. Neurosci. 2011, 159, 38-44.
14. Griendling, K.K.; Minieri, C.A.; Ollerenshaw, J.D.; Alexander, R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994, 74, 1141-1148.
15. Rajagopalan, S.; Kurz, S.; Munzel, T.; Tarpey, M.; Freeman, B.A.; Griendling, K.K.; Harrison, D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NAD(P)H oxidase activation: Contribution to alterations of vasomotor tone. J. Clin. Investig. 1996, 97, 1916-1923.
16. American Heart Association. Heart disease and stroke statistics - 2008 update. Circulation 2008, 117, 125-146.
17. Lefkowits, R.J.; Willerson, J. Prospects for cardiovascular research. JAMA 2001, 285, 581-587.
18. Queiroz, T.M.; Machado, N.T.; Furtado, F.F.; Oliveira-Filho, A.A.; Alustau, M.C.; Figueiredo, C.S.; Miranda, G.E.C.; Barbosa-Filho, J.M.; Braga, V.A.; Medeiros, I.A. Vasorelaxation induced by Dictyota pulchella (Dictyotaceae), a brown alga, is mediated via inhibition of calcium influx in rats. Mar. Drugs 2011, 9, 2075-2088.
19. Chen, X.; Touyz, R.M.; Park, J.B.; Schiffrin, E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001, 38, 606-611.
20. Hong, H.J.; Hsiao, G.; Cheng, T.H.; Yen, M.H. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001, 38, 1044-1048.
21. Costa, C.A.; Amaral, T.A.; Carvalho, L.C.; Ognibene, D.T.; da Silva, A.F.; Moss, M.B.; Valença, S.S.; de Moura, R.S.; Resende, A.C. Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am. J. Hypertens. 2009, 22, 1242-1249.
22. Landmesser, U.; Dikalov, S.; Price, S.R.; Mc-Cann, L.; Fukai, T.; Holland, S.M.; Mitch, W.E.; Harrison, D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Investig. 2003, 111, 1201-1209.
23. Grassi, G.; Cattaneo, B.M.; Seravalle, G.; Lanfranchi, A.; Mancia, G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998, 31, 68-72.
24. Salgado, M.C.; Justo, S.V.; Joaquim, L.F.; Fazan, R., Jr.; Salgado, H.C. Role of nitric oxide and prostanoids in attenuation of rapid baroreceptor resetting. Am. J. Physiol. Heart Circ. Physiol. 2009, 290, 1059-1063.
25. Pechánová, O.; Zichaj, J.; Kojsová, S.; Dobesová, Z.; Jendekovál, L.; Kunes, J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin. Sci. 2006, 110, 235-242.
26. Contreras, F.; de La Parte, M.A.; Cabrera, J.; Ospino, N.; Israili, Z.H.; Velasco, M. Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension. Am. J. Ther. 2003, 10, 401-408.
27. Berk, B.C.; Vekshtein, V.; Gordon, H.M.; Tsuda, T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989, 13, 305-314.
28. Geisterfer, A.A.; Peach, M.J.; Owens, G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 1988, 62, 749-756.
29. Naftilan, A.J.; Gilliland, G.K.; Eldridge, C.S.; Kraft, A.S. Induction of the proto oncogene c-jun by angiotensin II. Mol. Cell. Biol. 1990, 10, 5536-5540.
30. Neyses, L.; Nouskas, J.; Luyken, J.; Fronhoffs, S.; Oberdorf, S.; Pfiefer, U.; Williams, R.S.; Sukhatme, V.P.; Vetter, H. Induction of immediateearly genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J. Hypertens. 1993, 11, 927-934.
31. 2+ mobilization and protein kinase C activation. J. Biol. Chem. 1989, 264, 526-530.
32. Everett, A.D.; Tufro-McReddie, A.; Fisher, A.; Gomez, R.A. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 1994, 23, 587-592.
33. Fernandez-Alfonso, M.S.; Ganten, D.; Paul, M. Mechanisms of cardiac growth. The role of the renin-angiotensin system. Basic Res. Cardiol. 1992, 87, 173-181.
34. Himeno, H.; Crawford, D.C.; Hosoi, M.; Chobanian, A.V.; Brecher, P. Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension 1994, 23, 823-826.
35. Crawford, D.C.; Chobanian, A.V.; Brecher, P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ. Res. 1994, 74, 727-739.
36. Berry, C.; Hamilton, C.A.; Brosnan, M.J.; Magill, F.G.; Berg, G.A.; McMurray, J.J.; Dominiczak, A.F. Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000, 101, 2206-2212.
37. Zimmerman, M.C.; Lazartigues, E.; Sharma, R.V.; Davisson, R.L. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 2004, 95, 210-216.
38. Lassegue, B.; Clempus, R.E. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285, 277-297.
39. Hirooka, Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton. Neurosci. 2008, 142, 20-24.
40. Monahan, K.D.; Eskurza, I.; Seals, D.R. Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, 2113-2117.
41. Nishi, E.E.; Oliveira-Sales, E.B.; Bergamaschi, C.T.; Oliveira, T.G.; Boim, M.A.; Campos, R.R. Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am. J. Hypertens. 2010, 23, 473-480.
42. Li, Z.; Mao, H.Z.; Abboudm, F.M.; Chapleau, M.W. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ. Res. 1996, 79, 802-811.
43. Nightingale, A.K.; Blackman, D.J.; Field, R.; Glover, N.J.; Pegge, N.; Mumford, C.; Schmitt, M.; Ellis, G.R.; Morris-Thurgood, J.A.; Frenneaux, M.P. Role of nitric oxide and oxidative stress in baroreceptor dysfunction in patients with chronic heart failure. Clin. Sci. 2003, 104, 529-535.
44. Chapleau, M.W.; Cunningham, J.T.; Sullivan, M.J.; Wachtel, R.E.; Abboud, F.M. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995, 26, 341-347.
45. Shay, K.P.; Moreau, R.F.; Smith, E.J.; Smith, A.R.; Hagen, T.M. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life 2008, 60, 362-367.
46. San Jose, G.; Fortuno, A.; Beloqui, O.; Diez, J.; Zalba, G. NADPH oxidase CYBA polymorphisms oxidative stress and cardiovascular diseases. Clin. Sci. (Lond.) 2008, 114, 173-182.
47. Judge, E.P.; Phelan, D.; O'Shea, D. Beyond statin therapy: A review of the management of residual risk in diabetes mellitus. J. R. Soc. Med. 2010, 103, 357-362.
48. 2+ Homeostasis Disorders. Molecules 2010, 15, 7167-7187.
49. Braga, V.A. Dietary salt enhances angiotensin-II-induced superoxide formation in the rostral ventrolateral medulla. Auton. Neurosci. Basic Clin. 2010, 155, 14-18.
50. Braga, V.A.; Burmeister, M.A.; Sharma, R.V.; Davisson, R.L. Cardiovascular responses to peripheral chemoreflex activation and comparison of different methods to evaluate baroreflex gain in conscious mice using telemetry. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295, 1168-1174.